LAXMIDENTL · Laxmi Dental Ltd · Medical Equipment & Supplies
LAXMIDENTL · Laxmi Dental Ltd · Medical Equipment & Supplies
As of 05 Nov close
52-week range
43.0% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 15 Sep 2026 · the company's own latest record is 52 days old
Revenue (latest Q)
₹75 Cr
Revenue YoY
PAT YoY
+22.8%
Operating margin
Revenue, last 8 quarters
P/E (TTM)
P/B
4.5
P/S (TTM)
3.9
Sector P/E
Not available from data source
Dividend yield
0.0%
| Company | P/E | P/B | Net margin | ROE | D/E | Div. yield |
|---|---|---|---|---|---|---|
| LAXMIDENTL (this stock) | 40.1 | 4.5 | +10.8% | +12.7% | 0.05 | 0.0% |
| Lenskart Solutions | 135.7 | 21.5 | +6.8% | +7.5% | 0.35 | 0.0% |
| Poly Medicure | 54.3 | 6.5 | +15.8% | +10.1% | 0.11 | +0.2% |
| One Global Service Provider | 17 | 8.3 | +13.9% | +65.2% | 0.02 | Not available from data source |
Promoter
stable
FII
falling 2q
MF
10.11% (-0.21pp)
falling 3q
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| canonicalSymbol | date | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| LAXMIDENTL | 2026-05-22 | 620420 | 2 | WEAK | BULK |
News timeline
- mediumcorporate actionthehindubusinessline.com· 04 Nov 2026, 10:05 pmQ2 Results Today Highlights: BSE, Apollo Hospitals, Sundaram Finance post higher profit in Q2; Biocon, Zydus Life profit declines
- lowthehindubusinessline.com· 04 Nov 2026, 09:28 amQ2 Results 04th Nov Live: BSE, Cummins, Zydus Lifesciences, Apollo, Lenskart, Nykaa, Aurobindo Pharma, NHPC, Dabur, Torrent Power, Biocon, Sundaram Finance, Premier Energies, Physicswallah to announce
Concalls & investor presentations
AI-generatedKey takeaway: Management reported that Q1 FY27 was a strong quarter for Laxmi Dental Limited, with revenue reaching approximately INR 75 crores, a year-on-year growth of 13.9%, marking the highest quarterly revenue in the company's history. EBITDA grew by 20.6% year-on-year, with margins improving to 19.2%, while profit after tax (PAT) increased by 23.8% year-on-year, with margins at 13.8%. The dental lab business saw a revenue increase of 23.5% year-on-year, driven by both domestic and international markets, with international growth at 37.4%. Management highlighted the appointment of a new CEO for the USA business to enhance market strategy. The aligner solutions segment also performed well, with a 28.6% year-on-year growth. Management discussed plans for investments in new machinery and a transition to a new owned facility to improve operational efficiency. The company aims to continue expanding market reach and product innovation.
Management emphasized strong growth and positive developments across various business segments.
Sourced from an exchange-filed transcript, dated 19 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Laxmi Dental Limited reported a strong start to FY27, achieving record quarterly revenue of approximately ₹75.0 crore, reflecting a year-on-year growth of 13.9%. Management highlighted that this performance was driven by growth in both the Dental Laboratory and Aligner Solutions businesses, with the former growing by 23.5% and the latter by 28.6%. The company noted improvements in profitability due to a favorable product mix and emphasized its strategic initiatives, including expanding its leadership presence in the U.S. and establishing new support facilities in India. The presentation also detailed financial metrics, including a gross profit margin of 78.6% and an EBITDA margin of 19.2%. Management expressed confidence in sustaining growth through a focus on core dental products, market penetration, and operational efficiencies.
Management emphasized strong financial performance and growth initiatives.
Sourced from an exchange-filed presentation, dated 11 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Laxmi Dental Limited reported strong performance in its Q4 FY '26 earnings conference call, with revenue reaching INR 74 crores, a 22% year-on-year increase. Management highlighted a gross profit margin of 70.5% and noted that EBITDA and PAT margins were 18.3% and 13.6%, respectively. The company faced challenges such as US tariff volatility and competition in the aligner segment but managed to close the year with a 16.2% growth overall. The domestic dental lab business grew by 16.3%, while international operations saw a robust 40.9% growth. Management emphasized the importance of digitalization and introduced a new AI-connected remote dental platform, iScope 360, aimed at enhancing patient-dentist interactions. The company remains focused on expanding its international presence and diversifying its business across geographies. Overall, management expressed confidence in the long-term growth potential of the dental market in India.
Management emphasized strong performance and growth despite challenges.
Sourced from an exchange-filed transcript, dated 30 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Laxmi Dental Limited reported a revenue of INR 66 crores for Q3FY26, reflecting a year-on-year growth of 7.1% compared to INR 61.7 crores in the same period last year. Management noted that this performance occurred despite a challenging global environment. The gross profit margin improved slightly to 69.5%, while EBITDA and PAT margins were reported at 10.6% and 3%, respectively. Management highlighted a one-time impact of INR 5.8 crores due to new labor code requirements. The company experienced softness in its domestic lab and aligner solution business but implemented innovative strategies to address this. Management expressed confidence in achieving a strong exit for the year, supported by initiatives in digital dentistry and AI. The international business, particularly in the US, showed robust growth, aided by a reduction in tariffs from 50% to 25%. Overall, management conveyed optimism about future growth prospects.
Management conveyed optimism about growth prospects despite recent challenges.
Sourced from an exchange-filed transcript, dated 17 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: Laxmi Dental Limited's investor presentation for Q3FY26 reported revenues of INR 660 million, reflecting a year-on-year growth of 7% despite global economic challenges. Management noted a minor improvement in gross profit margins, attributed to steady profitability in the laboratory and aligner business, while scanner sales, which are low-margin, decreased. The company faced a full quarter impact of 150 basis points from higher US tariffs and recorded a one-time exceptional provision of INR 58 million related to gratuity under new labor codes. The dental lab business grew by 10.4% year-on-year, with international operations showing a robust 25.5% growth. Management expressed optimism about future growth driven by strategic initiatives and market consolidation. The presentation also highlighted the company's commitment to digital dentistry and its position as a leading player in the dental market.
Management highlighted growth and strategic positioning despite challenges.
Sourced from an exchange-filed presentation, dated 10 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedLaxmi Dental Limited's annual report for FY2025-26 highlights its position as India's only end-to-end integrated dental products company, emphasizing its digital transformation and expansion in the dental value chain. The report outlines the company's focus on corporate governance, ethical business practices, and strategic initiatives to enhance its market presence. It also details the company's financial performance, operational strategies, and compliance with regulatory standards.
- Commitment to corporate governance with a focus on transparency, integrity, and ethical conduct.
- Management expects expansion of digital penetration to approximately 75% in the Indian dental business, enhancing connectivity between dentists and laboratories.
- Strategic initiatives in product portfolio expansion, including Teen Aligners and Personalised Early Orthodontic Treatment.
- Emphasis on research and development in digital and AI-enabled dental solutions, such as iScope 360 and IDBG AI Dent.
Key takeaway: Laxmi Dental Limited is focused on digital transformation and corporate governance, with strategic initiatives to expand its product portfolio and enhance its market position through technological innovation.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
Regulatory Action (1 item)
Items of these kinds are disclosed in the filings. This is a count of disclosed items. It is not a finding about the company and its cause has not been independently established.
Regulatory Action
1 occurrenceRecent (last 12 months)
The company was fined INR 11,800 (including GST) by the National Stock Exchange of India Limited for non-compliance or delayed compliance with Regulation 23(9) of the Listing Regulations for the Quarter and Year ended 31 March, 2025.
Routine disclosures
Contingent Liability
1 occurrenceRecent (last 12 months)
The company has contingent liabilities and commitments as of 31 March, 2026, which are described in the annual report.
Related-Party Transaction
1 occurrenceRecent (last 12 months)
The company ratified related party transactions undertaken during the financial year, which were not approved by the Audit Committee prior to their execution, at a meeting held on 26 March 2026.